INNV InnovAge Holding Corp. Insider Trading

Director Richard C. Zoretic purchased 42,715 shares across 3 days for $173,306.60 at blended $4.06, raising stake 165.7%

Richard C. Zoretic, a Director at InnovAge Holding Corp., executed 3 separate purchases totaling 42,715 shares for $173,306.60 over May 28–30, 2025, at a blended average price of $4.06—substantially accumulating his position from 25,779 shares to 68,494 shares (+165.7%). This aggressive accumulation occurred across five consecutive trading days (May 16, 20–23, and May 28–30), representing a distinct pattern of discretionary open-market purchases. The company trades 35.7% below its 52-week high but has risen 30.7% over the past 30 days; however, InnovAge remains unprofitable with a net loss of $11.4M on $218.1M in quarterly revenue. His cross-ticker track record shows 5 prior buys, though none at this ticker have yet reached measurable 90-day windows. The sustained accumulation at this reduced valuation, combined with the director's willingness to deploy capital over multiple days and nearly triple his holdings, warrants attention to the underlying rationale and company fundamentals.

Director Richard C. Zoretic bought 3,045 shares across 3 transactions (5/21-5/23) for $12,308.25, blended at $4.04, raising holdings 13.4% to 25,779 shares

Director Zoretic made 3 separate purchases totaling 3,045 shares for $12,308.25 between May 21–23, 2025, at prices ranging from $3.93 to $4.13 and averaging $4.04. His holdings grew 13.4% from 22,734 to 25,779 shares. The stock currently trades at $3.93, which is -38.2% from its 52-week high of $6.36 but has rebounded +35.0% over the past 30 days and +18.4% over 90 days. InnovAge is currently unprofitable with a net loss of $-11,378,000.00 on revenue of $218,142,000.00 (latest quarter), though annual revenue grew +11.0%. This buying activity occurs at a depressed stock price relative to recent range, though Zoretic's cross-ticker track record shows only 2 prior buys and no measurable outcomes from those prior acquisitions at this ticker to establish a timing pattern.

Director Richard C Zoretic buys 2,893 shares in 2 tranches at $4.28–$4.20; holds 22,734 shares post-purchase.

Richard C Zoretic, a director at InnovAge Holding Corp., executed 2 purchases totaling 2,893 shares for $12,317.48 at a blended average price of $4.26 on May 16 and May 20, 2025. His holdings increased 14.6% relative to pre-transaction holdings of 19,841 shares. The company reported latest-quarter revenue of $218,142,000.00 but a net loss of $-11,378,000.00, and was unprofitable over its most recent full fiscal year. The stock is currently trading at $4.24, down 33.3% from its 52-week high of $6.36 and up 54.2% over the preceding 30 days. The purchase price proximity to current price and the timing relative to recent price momentum merit monitoring of INNV's financial trajectory.

President and COO Michael Scarbrough acquires 33,000 shares across 3 purchases for $122,890.00 at blended average of $3.72

Michael Scarbrough, as President and COO, executed 3 separate share purchases totaling 33,000 shares for $122,890.00 between May 9-13, 2025, establishing an initial equity stake after holding 0 shares pre-transaction. The purchases occurred at prices ranging from $3.55 to $3.89, and the current price of $3.96 sits 30 days up +40.4% from the transaction period, suggesting favorable near-term price movement relative to his entry prices. InnovAge reported revenue of $218,142,000.00 in the latest quarter with net income of $-11,378,000.00, indicating ongoing unprofitability despite annual revenue growth of +11.0%. The filing establishes a material executive position in an unprofitable company with positive revenue momentum, warranting investor examination of whether this represents leadership conviction in turnaround prospects or other corporate incentive structures.